Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

AstraZeneca Boasts of Pipeline as Analysts See Deal Ahead
Bloomberg
Friday, February 7, 2014 - 9:22am
tags:
AstraZeneca, roxadustat, kidney disease, non-small cell lung cancer, AZD9291
Merck Said to Agree to $100 Million NuvaRing Settlement
Bloomberg
Thursday, February 6, 2014 - 6:13pm
tags:
Merck, Nuvaring
Medicines Co. Awarded BARDA Contract
Yahoo/Zacks.com
Thursday, February 6, 2014 - 6:12pm
tags:
BARDA, The Medicines Company, Carbavance
Novo Nordisk Gives anti-NKG2A Rights to Innate
Yahoo/Zacks.com
Thursday, February 6, 2014 - 6:09pm
tags:
Innate Pharma S.A., Novo Nordisk, anti-NKG2A
Spectrum rises after saying FDA will make a decision on its lymphoma drug Beleodaq by Aug. 9
Yahoo/Reuters
Thursday, February 6, 2014 - 6:08pm
tags:
Spectrum Pharmaceuticals, FDA, Beleodaq, T-cell lymphoma
2014: End of the Road for the American Rx Salesperson?
Pharm Exec
Thursday, February 6, 2014 - 12:02pm
tags:
drug reps, layoffs
Merck's New Drugs Are Bringing New Hope
Seeking Alpha
Thursday, February 6, 2014 - 11:59am
tags:
Merck, Januvia, China, India, MK-3475
Circassia Plans $285 Million IPO to Fund Allergy Vaccines
Bloomberg
Thursday, February 6, 2014 - 10:18am
tags:
Circassia, IPOs, vaccines, allergies
AstraZeneca takes on Merck in Alzheimer's drug race
Yahoo/Reuters
Thursday, February 6, 2014 - 9:57am
tags:
AstraZeneca, Merck, Alzheimer's disease, AZD3293, BACE inhibitors
Revance Therapeutics IPO May Make You Look Good
Seeking Alpha
Thursday, February 6, 2014 - 9:54am
tags:
ReVance, IPOs
Smith & Nephew positive after strong finish to 2013
Reuters
Thursday, February 6, 2014 - 8:47am
tags:
devices, Smith & Nephew, earnings
Device makers skeptical of Google's glucose sensing contact lenses
Mass Device
Thursday, February 6, 2014 - 8:47am
tags:
devices, blood glucose monitoring, Google X
AstraZeneca quietly sweeps out some notable mid-stage drug programs
Fierce Biotech
Thursday, February 6, 2014 - 8:38am
tags:
AstraZeneca, MEDI-5117, AZD8330, AZD6765, MEDI-557, MEDI-575, AZD5423, AZD7594, AZD1446, AZD3480, AZD5213
AstraZeneca steps up its global restructuring with 550 new job cuts
Fierce Pharma
Thursday, February 6, 2014 - 8:35am
tags:
layoffs, AstraZeneca
AbbVie Expands Manufacturing Presence with US$320 Million Investment in Singapore
Yahoo
Thursday, February 6, 2014 - 7:50am
tags:
AbbVie, Singapore, drug manufacturing
St. Jude Medical announces first U.S. patient implant of non-surgical pacemaker
Yahoo/Fly on the Wall
Thursday, February 6, 2014 - 7:49am
tags:
St. Jude Medical, non-surgical pacemaker, devices, Nanostim
The Dream Of The Insulin Pill: Oramed Vs. Rivals
Seeking Alpha
Thursday, February 6, 2014 - 7:47am
tags:
insulin, diabetes, Oramed, oral insulin, ORMD-0801, NN1954, Novo Nordisk
Teva Pharm Q4 profit, revenue top estimates
Yahoo/Reuters
Thursday, February 6, 2014 - 7:45am
tags:
earnings, Teva Pharmaceuticals
Repros Meets With FDA to Discuss Data Requirements for Androxal(R) in the Treatment of Secondary Hypogonadism
Yahoo
Thursday, February 6, 2014 - 7:44am
tags:
Repros, FDA, Androxal, secondary hypogonadism
Gilead Sciences, Inc Has a Potential Blockbuster Drug for 2014
Motley Fool
Thursday, February 6, 2014 - 7:43am
tags:
Gilead Sciences, hepatitis C, Sovaldi

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.